Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term tumor-cells. Found 24 abstracts

no pagination
Cheng F, Wang HW, Horna P, Wang Z, Shah B, Sahakian E, Woan KV, Villagra A, Pinilla-Ibarz J, Sebti S, Smith M, Tao JG, Sotomayor EM. Stat3 Inhibition Augments the Immunogenicity of B-cell Lymphoma Cells, Leading to Effective Antitumor Immunity. Cancer Research. 2012 Sep;72(17):4440-8.   PMCID: No Longer Here
Swoboda RK, Somasundaram R, Caputo L, Berencsi K, von Franzke P, Taylor DD, Marincola FM, Meropol NJ, Sigurdson E, Miller E, Herlyn D. Nucleophosmin is recognized by a cytotoxic T cell line derived from a rectal carcinoma patient. International journal of cancer. 2010 Sep;127(5):1124-30.   PMCID: PMCID: PMC2897913 [Available on 2011/9/1]
Karp DD, Pollak MN, Cohen RB, Eisenberg PD, Haluska P, Yin DH, Lipton A, Demers L, Leitzel K, Hixon ML, Terstappen LW, Garland L, Paz-Ares LG, Cardenal F, Langer CJ, Gualberto A. Safety, Pharmacokinetics, and Pharmacodynamics of the Insulin-Like Growth Factor Type 1 Receptor Inhibitor Figitumumab (CP-751,871) in Combination with Paclitaxel and Carboplatin. Journal of Thoracic Oncology. 2009 Nov;4(11):1397-403.   PMCID: PMC2941876
Lewis-Wambi JS, Swaby R, Kim H, Jordan VC. Potential of L-buthionine sulfoximine to enhance the apoptotic action of estradiol to reverse acquired antihormonal resistance in metastatic breast cancer. Journal of Steroid Biochemistry and Molecular Biology. 2009 Mar;114(1-2):33-9.   PMCID: PMC28689080
Chmielewski M, Hombach A, Heuser C, Adams GP, Abken H. T cell activation by antibody-like immunoreceptors: Increase in affinity of the single-chain fragment domain above threshold does not increase T cell activation against antigen-positive target cells but decreases selectivity. Journal of Immunology. 2004 Dec 15;173(12):7647-53.
Cohen SJ, Meropol NJ. Drug development in pancreatic cancer - Finally, biology begets therapy. International Journal of Gastrointestinal Cancer. 2002 Jan;32(2-3):91-106.
Mgbonyebi OP, Russo J, Russo IH. Roscovitine induces cell death and morphological changes indicative of apoptosis in MDA-MB-231 breast cancer cells. Cancer Research. 1999 Apr 15;59(8):1903-10.
Calvert P, Yao KS, Hamilton TC, O'Dwyer PJ. Clinical studies of reversal of drug resistance based on glutathione. Chemico-Biological Interactions. 1998 Apr 24;112:213-24.
Vaisman A, Varchenko M, Umar A, Kunkel TA, Risinger JI, Barrett JC, Hamilton TC, Chaney SG. The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: Correlation with replicative bypass of platinum-DNA adducts. Cancer Research. 1998 Aug 15;58(16):3579-85.
Yao KS, Hageboutros A, Ford P, Odwyer PJ. Involvement of activator protein-1 and nuclear factor-kappa B transcription factors in the control of the DT-diaphorase expression induced by mitomycin C treatment. Molecular Pharmacology. 1997 Mar;51(3):422-30.
Huang LG, Lang D, Geradts J, Obara T, KleinSzanto AJ, Lynch HT, Ruggeri BA. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines. Molecular Carcinogenesis. 1996 Feb;15(2):85-95.
Odwyer PJ, Hamilton TC, LaCreta FP, Gallo JM, Kilpatrick D, Halbherr T, Brennan J, Bookman MA, Hoffman J, Young RC, Comis RL, Ozols RF. Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer. Journal of Clinical Oncology. 1996 Jan;14(1):249-56.
Paul S, Belinsky MG, Shen HX, Kruh GD. Structure and in vitro substrate specificity of the murine multidrug resistance-associated protein. Biochemistry. 1996 Oct 22;35(42):13647-55.
Paul S, Breuninger LM, Kruh GD. ATP-dependent transport of lipophilic cytotoxic drugs by membrane vesicles prepared from MRP-overexpressing HL60/ADR cells. Biochemistry. 1996 Nov 05;35(44):14003-11.
Rose GS, Tocco LM, Granger GA, DiSaia PJ, Hamilton TC, Santin AD, Hiserodt JC. Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat. American journal of obstetrics and gynecology. 1996 Sep;175(3):593-9.
Crilley P, Goldstein LJ. Peripheral-Blood Stem-Cell Transplant in Breast-Cancer. Seminars in Oncology. 1995 Jun;22(3):238-49.
Smith CD, Zilfou JT. Circumvention of P-Glycoprotein-Mediated Multiple-Drug Resistance by Phosphorylation Modulators Is Independent of Protein-Kinases. Journal of Biological Chemistry. 1995 Nov 24;270(47):28145-52.
Moutschen MP, Shan H, Giantonio BJ, Bookman MA. Precursor Ctl Specific for Retrovirus-Induced T-Lymphoma Are Found at High-Frequency in Unprimed Syngeneic Mice. Cellular Immunology. 1994 Feb;153(2):367-77.
Weiner LM, Li W, Holmes M, Catalano RB, Dovnarsky M, Padavic K, Alpaugh RK. Phase-I Trial of Recombinant Macrophage-Colony-Stimulating Factor and Recombinant Gamma-Interferon - Toxicity, Monocytosis, and Clinical Effects. Cancer Research. 1994 Aug;54(15):4084-90.
Calaf G, Russo J. Transformation of Human Breast Epithelial-Cells by Chemical Carcinogens. Carcinogenesis. 1993 Mar;14(3):483-92.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term tumor-cells

tumor-cells expression cyto-toxicity lymphocytes phase-i pancreatic cancer melphalan depletion cytotoxicity cell-lines activation liver canalicular membrane multidrug-resistance mice cancer l-phenylalanine mustard inhibition carcinoma antigens gene mouse bioactivation Her-2 Low dose estrogen therapy Antihormone resistance-Apoptosis-Breast cancer-L-Buthionine sulfoximine-Glutathione microsatellite instability phase-i trial cells in-vivo recognition breast cancer-cells disease-free survival cyclin-dependent kinases adjuvant chemotherapy transcription factor-i atp-dependent transport monoclonal- mutations 871 CP-751 tamoxifen npm epithelial- genes progression gene- colony-stimulating factor induction line hl60 cells colony- altered expression clinical-trial cancer cell-lines term follow-up sulfoximine binding protein-3 stimulating factor bladder-cancer electrophiles cytotoxic t-lymphocytes resistance-associated protein immunotherapy hl-60 cells single-strand conformation polymorphism colorectal-cancer ovarian-cancer cells VEGF cytolytic lymphocytes-t animal model progenitor cells invitro assay retinoblastoma susceptibility gene staurosporine actin stress human mismatch repair xanthine dehydrogenase carrier-ligand immune-response ovarian cancer polymerase-delta complex class-i hypoxia matrix metalloproteinase inhibitors product rat mammary-gland potent inhibitor kb cells dendritic cells p-glycoprotein phorbol esters cd28 costimulation reductive activation glutathione synthesis toxicity murine leukemia glycoprotein NSCLC neoplastic transformation prognostic factors growth-factors fibers identification monoclonal-antibody secretion drug-resistant drug-resistance neoplasms fc-receptors amplification transplantation colon-cancer transformation 871 monoclonal-antibody cp-751 invitro alkylating-agents extracellular-matrix leukemia-cells cell lung-cancer estrogen deprivation intracellular glutathione FTI chemotherapy in-vitro therapy neu immunogenicity buthionine immunohistochemistry s-transferase homeostasis clones glutathione modulation tcr selective inhibitor doxorubicin growth-factor receptor survival retinoblastoma gene protein drug accumulation mammalian-cells EGFR ovarian neoplasm endocrine therapy cells invivo NuTu-19 human peripheral-blood multistep nature high-dose chemotherapy mrp gene
Last updated on Sunday, August 09, 2020